Letrozole 2.5mg

$69.00

ACTIVE HALF-LIFE: 2 DAYS
CLASSIFICATION: NON-STEROIDAL AROMATASE INHIBITOR
DOSAGE: 0.5 – 2.5 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOXITY: NO
AROMATIZATION: NO

Description

Letrozole, a product from Ultima Pharmaceuticals, is an anti-estrogen agent that has gained widespread recognition in both medical and sports applications. In the medical field, it is primarily employed for treating estrogen-related neoplastic diseases, particularly breast cancer in women. In sports, it is utilized to mitigate the adverse effects of estrogenic steroids, ranging from water retention to gynecomastia in men, among other concerns.

This drug is a non-steroidal aromatase inhibitor, and its active ingredient is Letrozole. Letrozole has been approved for human use, distinguishing itself as non-steroidal, devoid of androgenic activity, non-toxic to the liver, and lacking narcotic or addictive properties.

Letrozole Effects:

Letrozole, manufactured by Bouwen, acts as an inhibitor of aromatase, an enzyme crucial in estrogen formation. Its mechanism of action involves inhibiting the cytochrome P450 genome within aromatase. Through extended use, the drug induces a reduction in estrogen activity by 75-95% from baseline.

Belonging to the third and latest generation of aromatase inhibitors, Letrozole shares similarity with Anastrozole but differs from Clomid and Nolvadex, which function as estrogen receptor blockers. Letrozole affects the production of estrogen itself, unlike the latter drugs that solely bind to estrogen receptors in the body.

It’s crucial to note that Letrozole from Bouwen is relatively safe when used in accordance with recommendations, causing minimal side effects. However, in cases of predisposition and misuse, complications affecting the digestive, central nervous, respiratory, and musculoskeletal systems may arise. Symptomatic treatment is generally employed in cases of overdose.

How to Use Letrozole: Dosage, Cycle, Reviews:

Administration of the drug is exclusively oral, irrespective of food intake. It is rapidly and completely absorbed from the gastrointestinal tract, with a bioavailability reaching 99%, unaffected by food intake.

The recommended Letrozole dosage ranges from 0.25 to 5 mg per day, depending on individual needs and tolerance. Usage typically follows one of two possible schemes: preventive use before a cycle of estrogenic steroids to avert complications or additional use throughout the steroid cycle to address estrogen-related complications.

Letrozole effectively prevents the development of estrogen-related side effects, including water retention, body fat growth, and gynecomastia in men.

Before initiating Ultima-Femara use, it is imperative to assess potential risks through consultation with a specialist, excluding contraindications, such as pregnancy, lactation, endocrine status characteristic of reproductive age, intolerance to substances, hypersensitivity to drug components, and children’s age.

There are also precautions to observe, such as glucose-galactose malabsorption, lactase deficiency, and lactase intolerance, which may necessitate caution. Adjustment of doses is generally not required for this drug.

Warnings: Keep Letrozole out of reach of children. Intended for adult use only.

There are no reviews yet.

Be the first to review “Letrozole 2.5mg”

Your email address will not be published. Required fields are marked *